MAGNESIUM SULFATE IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Magnesium Sulfate In Plastic Container patents expire, and what generic alternatives are available?
Magnesium Sulfate In Plastic Container is a drug marketed by Amneal, Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Hq Spclt Pharma, Milla Pharms, and Mylan Labs Ltd. and is included in eight NDAs.
The generic ingredient in MAGNESIUM SULFATE IN PLASTIC CONTAINER is magnesium sulfate. There are one hundred and forty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Magnesium Sulfate In Plastic Container
A generic version of MAGNESIUM SULFATE IN PLASTIC CONTAINER was approved as magnesium sulfate by FRESENIUS KABI USA on September 8th, 1986.
Summary for MAGNESIUM SULFATE IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 12 |
Raw Ingredient (Bulk) Api Vendors: | 137 |
Clinical Trials: | 314 |
Patent Applications: | 1,386 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MAGNESIUM SULFATE IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for MAGNESIUM SULFATE IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cukurova University | Phase 4 |
Southeastern Ontario Academic Medical Organization (SEAMO) | Phase 4 |
National Institutes of Health (NIH) | Phase 2 |
See all MAGNESIUM SULFATE IN PLASTIC CONTAINER clinical trials
Pharmacology for MAGNESIUM SULFATE IN PLASTIC CONTAINER
Anatomical Therapeutic Chemical (ATC) Classes for MAGNESIUM SULFATE IN PLASTIC CONTAINER
US Patents and Regulatory Information for MAGNESIUM SULFATE IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 216597-001 | Feb 15, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hq Spclt Pharma | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 207350-001 | Dec 6, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Milla Pharms | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209642-002 | Nov 8, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Fresenius Kabi Usa | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 206485-004 | Mar 15, 2016 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Baxter Hlthcare Corp | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 211966-002 | Jun 1, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Gland Pharma Ltd | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 213917-002 | Jul 10, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hq Spclt Pharma | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 207350-003 | Dec 6, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |